Subacute effects of ecstasy on mood: An exploration of associated risk factors

Journal of Psychopharmacology

Volumn 27, Issue 1, 2013, Pages 53-61

  Scott, Rebecca M ^a,b   Hides, Leanne ^c   Allen, J Sabura ^a   Lubman, Dan I ^a  

^a MONASH UNIVERSITY   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Ecstasy; mood; risk factors; sleep; subacute

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; AGGRESSIVENESS; ANXIETY DISORDER; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; DRUG EFFICACY; DRUG USE; FEMALE; FOLLOW UP; HOSTILITY; HUMAN; KESSLER 10; LIFE STRESS; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRIORITY JOURNAL; RATING SCALE; RISK ASSESSMENT; SELF REPORT; SIDE EFFECT; SLEEP DISORDER; SLEEP QUALITY; SLEEP TIME;

ADULT; AFFECT; ANXIETY; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL DISORDERS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SELF REPORT; SLEEP; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84871589625     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112463467     Document Type: Article

References (33)

1. Allott K, Redman J. Are there sex differences associated with the effects of ecstasy/3,4 methylenedioxymethamphetamine (MDMA)?. Neurosci Biobehav Rev. 2007 ; 31: 327-347
2. Andrews G, Slade T. Interpreting scores on the Kessler Psychological Distress Scale (K10). Aust N Z J Public Health. 2001 ; 25: 494-497
3. Bedi G, Redman J. Recreational ecstasy use: acute effects potentiated by ambient conditions. Neuropsychobiology. 2006 ; 53: 113
4. Curran HV, Rees H, Hoare T, et al. Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology. 2004 ; 173: 425-433
5. Curran HV, Travill RA. Mood and cognitive effects of 3,4- methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. Addiction. 1997 ; 92: 821-831
6. Goldberg D. A bio-social model for common mental disorders. Acta Psychiatr Scand. 1994 ; 90: S66 - S70
7. Green AR, Mechan AO, Elliott JM, et al. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol Rev. 2003 ; 55: 463-508
8. Hoshi R, Pratt H, Mehta S, et al. An investigation into the sub-acute effects of ecstasy aggressive interpretive and aggressive mood-are there gender differences?. J Psychopharmacol. 2006 ; 20: 291-301
9. Huxster JK, Pirona A, Morgan MJ. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans. J Psychopharmacol. 2006 ; 20: 281-290
10. Keane MA, James JE. Effects of dietary caffeine on EEG, performance and mood when rested and sleep restricted. Hum Psychopharmacol. 2008 ; 23: 669-680
11. Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major depression in women. Am J Psychiatry. 2002 ; 159: 1133-1145
12. Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major depression in men. Am J Psychiatry. 2006 ; 163: 115-124
13. Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002 ; 32: 959-976
14. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity. 2005 ; 95: 221-227
15. Liechti ME, Gamma A, Vollenweider FX. Gender differences in the subjective effects of MDMA. Psychopharmacology. 2001 ; 154: 161-168
16. Liechti ME, Vollenweider FX. Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Hum Psychopharmacol. 2001 ; 16: 589-598
17. McKenna DJ, Peroutka SJ. Neurochemistry and neurotoxicity of 3,4 methylenedioxymethamphetamine (MDMA, 'ecstasy'). J Neurochem. 1990 ; 54: 14-22
18. Parrot AC, Lasky J. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology. 1998 ; 139: 261-268
19. Parrott A, Rodgers J, Buchanan T, et al. Dancing hot on ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users. Hum Psychopharmacol. 2006 ; 21: 285-298
20. Pirona A, Morgan MJ. An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users. J Psychopharmacol. 2010 ; 24: 175-185
21. Quinn C, Dunn M, Degenhardt L EDRS Drug Trends Bulletin. Sydney: National Drug and Alcohol Research Centre, University of New South Wales ; 2007 2007 :
22. Scott RM, Hides L, Allen JS, et al. Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use. Psychopharmacology. 2010 ; 209: 25-26
23. Sobell LC, Sobell MB Measuring Alcohol Consumption: Psychosocial and Biological Methods. Allen RLJ, ed. Totowa, New Jersey: Humana Press ; 1992: 159-172.
24. Solowij N, Hall W, Lee N. Recreational MDMA use in Sydney: a profile of 'ecstasy' users and their experiences with the drug. Addiction. 1992 ; 87: 1161-1172
25. Steer RA, Schut J. Types of psychopathology displayed by heroin addicts. Am J Psychiatry. 1979 ; 136: 1463-1465
26. Sumnall HR, Cole JC. Self-reported depressive symptomatology in community samples of polysubstance misusers who report ecstasy use: a meta- analysis. J Psychopharmacol. 2005 ; 19: 84-92
27. Topp L, Hando J, Dillon P, et al. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend. 1999 ; 55: 105-115
28. Ventura J, Green MF, Shaner A, et al. Training and quality assurance with the Brief Psychiatric Rating Scale: 'the drift busters.'. Int J Methods Psychiatr Res. 1993 ; 3: 221-224
29. Verheyden SL, Hadfield J, Calin T. Sub-acute effects of MDMA (+/3,4 methylenedioxymethamphetamine, 'ecstasy') on mood: evidence of gender differences. Psychopharmacology. 2002 ; 161: 23-31
30. Verheyden SL, Henry JA, Curran H. Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users. Hum Psychopharmacol. 2003 ; 18: 507-517
31. Watson D, Clark LA The Mood and Anxiety Symptom Questionnaire. Iowa City: University of Iowa ; 1991 :
32. Watson D, Weber K, Assenheimer JS, et al. Testing a tripartite Model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. J Abnorm Psychol. 1995 ; 104: 3-14
33. Westermeyer J, Tucker P, Nugent S. Comorbid anxiety disorder among patients with substance use disorders: risk factors on initial evaluation. Am J Addict. 1995 ; 4: 97-106